pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$MAPSWM TECHNOLOGY, INC.

$MAPS0.4170+1.46%
Irvine, CA, USupdated 1mo ago
SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
0
marketed
0
phase 3
0
catalysts ytd
2
approvals ytd
0
recalls ytd
1

Pipeline(0)

no pipeline products on record

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →
🐶 Hiring Signal
No open roles indexed yet — view WM TECHNOLOGY, INC. jobs →

News

  • ADARx scores upsized $446M IPO, while fellow RNA biotech City maps out Nasdaq plans
    ADARx Pharmaceuticals has overshot its own IPO ambitions, as fellow RNA-focused biotech City Therapeutics also plans a public listing.
    fiercebiotech · 10d ago
  • Purer fentanyl won’t solve the U.S. overdose death crisis, study says
    Cautious optimism in the Ebola outbreak, FDA still stymied by DOGE cuts, and other health updates from the Morning Rounds newsletter.
    stat · 17d ago
  • Opinion: John Fetterman’s post-stroke, politically problematic behaviors offer lessons about brain health on Capitol Hill
    “Nothing in the recent reporting about John Fetterman is medically surprising,” write Michael P.H. Stanley and Isaiah Kletenik.
    stat · 25d ago
  • Opinion: What STAT readers think about M.D. vs. D.O., AI in medicine, surrogacy, and more
    “A click, signature, or brief review should not magically transfer responsibility from an AI developer or platform to a physician,” a reader tells STAT.
    stat · 1mo ago
  • Research into protein interactions sheds new light on causes of autism
    Studying protein-protein interactions might hold the key to identifying druggable targets for autism, a group of scientists at the University of California, San Francisco has suggested.
    fiercebiotech · 1mo ago
  • Pharma marketers need a share-of-answer strategy before AI spend
    AI is changing how HCPs seek answers. Pharma marketers need a new strategy.
    biopharma_dive · 1mo ago
  • Opinion: STAT readers debate blue zones, open-access publishing fees, and more
    Keep those letters coming!
    stat · 3mo ago
  • STAT+: Human Cell Atlas leader’s tie to 10x Genomics raises conflict-of-interest questions
    As the Human Cell Atlas project marks its 10th anniversary, a leader's ties to a major single-cell RNA sequencing company raise conflict-of-interest questions.
    stat · 3mo ago
  • Study highlights influence of socioeconomic status on children’s brain development
    A new study found that the leading environmental factor influencing brain structure and function is the socioeconomic status of a child's family.
    stat · 3mo ago
  • Updated: Allen Institute launches $400M effort to turn brain atlas lessons into medicines
    A Seattle-based nonprofit known for basic brain research is launching a $400 million initiative to translate its knowledge into drug development for neurodegenerative diseases, including Alzheimer'…
    endpoints · 4mo ago
view all news mentions →
identifiers
ticker
$MAPS
SEC CIK
0001779474
country
US
source
sec_tickers
mentioned in
10news items
entity-linker matched
Data sources
SEC EDGAR · openFDA
last refreshed 40m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?